Literature DB >> 19738495

A rare case of infantile myofibromatosis and review of literature.

Peter A Hausbrandt1, Andreas Leithner, Alfred Beham, Koppany Bodo, Johannes Raith, Reinhard Windhager.   

Abstract

Infantile myofibromatosis is a rare benign tumor-disease (1/400,000). Four different types have been reported in literature. The most commonly affected body areas are the head, the neck, and the trunk. We would like to present a rare case of a multicentric type with singular visceral involvement and a literature review of all case series with more than five patients. A 9-month-old boy presented with a swelling on the medial side of his proximal left tibia. The lesion which was present since birth, was well palpable, indolent, hard, and mobile in relation to the surrounding tissue. Radiographic films and ultrasound examination presented a pretibial soft-tissue tumor mass with calcifications and two osteolytic lesions with a sclerotic rim. A skeletal survey showed more osteolytic lesions, but the magnetic resonance imaging showed no more soft-tissue lesions. The rapid frozen section biopsy hinted at the diagnosis of histiocytosis X. The definitive histological result 6 days later was infantile myofibromatosis. As therapy, we determined a wait-and-see policy with controls all 3 months. At 20 months follow-up, the boy showed beginning of regression of all lesions. Infantile myofibromatosis is a very rare benign tumor-disease. Radiologically often soft-tissue masses with calcifications and osteolytic lesions with sclerotic rims are described. These findings also can be interpreted as histiocytosis X, which is a potential differential diagnosis. Histopathologically, cells characteristically appear as spindle-shaped fibroblast cells with pale pink cytoplasm and elongated nuclei and the immunophenotype is defined with a positive reaction on smooth-muscle antigen vimentin and the muscle-specific antigen HHF-35. The data of the literature review underline that a wait-and-see-policy should be considered as the first treatment of choice as in most instances the bony lesions regress spontaneously. However, a thorough examination has to be carried out to exclude lesion in other organs like gastro-intestinal or cardio-pulmonary nodular tumor masses. In conclusion, the present case report and the literature review support the notion that infantile myofibromatosis should be considered as a possible differential diagnosis for soft tissue expansions and/or osteolytic lesions in a newborn.

Entities:  

Mesh:

Year:  2010        PMID: 19738495     DOI: 10.1097/BPB.0b013e32832e4756

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  8 in total

1.  Imaging findings in seven cases of congenital infantile myofibromatosis with cerebral, spinal, or head and neck involvement.

Authors:  Laura Holzer-Fruehwald; Susan Blaser; Andrea Rossi; Julia Fruehwald-Pallamar; Majda M Thurnher
Journal:  Neuroradiology       Date:  2012-11-16       Impact factor: 2.804

2.  Infantile myofibromatosis of the iliac bone.

Authors:  Olivier Rosello; Virginie Rampal; Carlo Doria; Carlo Bertoncelli; Jean-Luc Clément; Federico Solla
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

3.  Solitary infantile myofibromatosis in the bones of the upper extremities: Two rare cases and a review of the literature.

Authors:  Weiliang Wu; Jiansong Chen; Xinfang Cao; Min Yang; Jian Zhu; Guoqiang Zhao
Journal:  Oncol Lett       Date:  2013-09-12       Impact factor: 2.967

4.  Diagnosis of infantile myofibromatosis with pseudo-ulcerated plaque using prenatal ultrasound: A case report.

Authors:  Feixue Zhang; Dongfeng Cheng; Mei Wu; Ling Ge; Xiangxing Ma
Journal:  Exp Ther Med       Date:  2014-10-08       Impact factor: 2.447

5.  Primary Resection and Immediate Autologous Reconstruction of Fronto-orbital Infantile Myofibromatoses.

Authors:  Jennifer L Lavie; Camille L Rogers; Mark W Stalder; Hugo St Hilaire
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-22

6.  Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis.

Authors:  Martin Sramek; Jakub Neradil; Petra Macigova; Peter Mudry; Kristyna Polaskova; Ondrej Slaby; Hana Noskova; Jaroslav Sterba; Renata Veselska
Journal:  Int J Mol Sci       Date:  2018-09-01       Impact factor: 5.923

7.  Prenatally Diagnosed Infantile Myofibroma of Sartorius Muscle-A Differential for Soft Tissue Masses in Early Infancy.

Authors:  Ștefan Popa; Dan Apostol; Ovidiu Bîcă; Diana Benchia; Ioan Sârbu; Carmen Iulia Ciongradi
Journal:  Diagnostics (Basel)       Date:  2021-12-18

8.  Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group.

Authors:  Simone Hettmer; Guillaume Dachy; Guido Seitz; Abbas Agaimy; Catriona Duncan; Marjolijn Jongmans; Steffen Hirsch; Iris Kventsel; Uwe Kordes; Ronald R de Krijger; Markus Metzler; Orli Michaeli; Karolina Nemes; Anna Poluha; Tim Ripperger; Alexandra Russo; Stephanie Smetsers; Monika Sparber-Sauer; Eveline Stutz; Franck Bourdeaut; Christian P Kratz; Jean-Baptiste Demoulin
Journal:  Fam Cancer       Date:  2020-09-05       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.